
    
      Adiana Post-Approval Clinical Study is a prospective, single armed, multi-center,
      observational study that is designed to provide additional efficacy and safety data regarding
      the FDA-approved Adiana Permanent Contraception System. This study will be conducted at 8-10
      clinical sites and enroll 1000 subjects. Enrolled subjects will have baseline data collected
      at the time of their Adiana procedure and will then be followed for a period of 2 years with
      visits occurring at 3 months following the Adiana procedure, 6 months following Adiana
      procedure (as applicable), 12 and 24 months post relying date.
    
  